Exact Mass: 430.258
Exact Mass Matches: 430.258
Found 500 metabolites which its exact mass value is equals to given mass value 430.258
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Trandolapril
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Trandolapril
Trandolapril is a non-sulhydryl prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is metabolized to its biologically active diacid form, trandolaprilat, in the liver. Trandolaprilat inhibits ACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Trandolapril may be used to treat mild to moderate hypertension, to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction, as an adjunct treatment for congestive heart failure, and to slow the rate of progression of renal disease in hypertensive individuals with diabetes mellitus and microalbuminuria or overt nephropathy. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
2-(2-Methylbutanoyl)-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one
2-(2-Methylbutanoyl)-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is found in tea. 2-(2-Methylbutanoyl)-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is a constituent of Tussilago farfara (coltsfoot). Constituent of Tussilago farfara (coltsfoot). 2-(2-Methylbutanoyl)-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is found in tea.
Piritramide
Piritramide (R-3365, trade names Dipidolor, Piridolan, Pirium and others) is a synthetic opioid analgesic with a potency 0.65 to 0.75 times that of morphine. A common starting dose is 15 mg IV, equivalent to 10 mg of morphine hydrochloride. Piritramide is commonly used for the treatment of postoperative pain. Piritramide was discovered at Janssen Pharmaceutica in 1960 and is currently manufactured and distributed within continental Europe and some other places by Janssen-Cilag. Piritramide is a strong opioid and therefore is regulated much the same as morphine in all known jurisdictions. It was never introduced in the United States and is therefore a Schedule I/Narcotic controlled substance. It is listed under international treaties and other laws such as the German Betabungsmittelgesetz, the Austrian Suchtgiftmittelgesetz, the Opium Laws of various other European countries, Canadian controlled substances act, UK Misuse of Drugs Act of 1971, and equivalents elsewhere. Strangely enough, bezitramide, which is not currently marketed in the United States is a Schedule II/Narcotic controlled substance. Piritramide is also known as pirinitramide. Its closest chemical relatives amongst well-known drugs are diphenoxylate (Lomotil) and bezitramide (Burgodin). Piritramide is available in tablets and ampoules of sterile solution for injection by all routes, and is used in Patient Controlled Analgesia units. In addition to PCA, piritramide is most often used in post-operative situations and emergency departments; some of its properties would seem to lend it well to chronic pain control as well. It is one of the longer-lasting opioids and has a plasma half-life of 3 to 12 hours. Piritramide tends to cause less respiratory depression than morphine and can take a while to have full effect especially if taken by mouth. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AC - Diphenylpropylamine derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics
Indolapril
Lupulone C
Lupulone C is a natural product found in Humulus lupulus with data available.
gutierrezianolic acid (2-methylbutyrate) methyl ester|gutierrezianolic acid <2-methylbutyrate> methyl ester
15alpha-Angeloyloxy-9beta-hydroxy-kaur-16-en-saeuremethylester|15alpha-angeloyloxy-stenolobin|ent-15beta-angeloxy-9alpha-hydroxykaur-16-en-19-oate|methyl 15alpha-angeloyloxy-9beta-hydroxy-ent-kaur-16-en-19-oate
12alpha-hydroxy-24-methyl-24,25-dioxoscalar-16-en-22-oic acid
9beta-hydroxy-15alpha-senecioyloxy-ent-kaurensaeure-methyl-ester
gutierrezianolic acid (isobutyrate) methyl ester|gutierrezianolic acid methyl ester
3beta-3,29-Dihydroxy-15-oxo-24,25,26-trinorlanosta-8,16-dien-23-oic acid
12alpha-(2-methylbutyryloxy)-hardwickiic acid methyl ester|12alpha-<2-methylbutyryloxy>-hardwickiic acid methyl ester
methyl-15beta-tiglinoyloxy-16,17-epoxy-ent-kaurane
methyl-3alpha-angeloyloxy-9beta-hydroxy-ent-kaurenoate
ent-7alpha-senecioxy-15alpha-hydroxy-atis-16-en-19-oic acid
rel-(1R,5R)-2-(1-farnesyl-5-acetoxy-2-oxocyclohex-3-en-1-yl)-acetic acid methyl ester
Val Ala Ile Glu
Val Ala Asn Lys
8-[2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)ethyl]-4a,7,8-trimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-2,3-diol
C22H38O8_Spiro[naphthalene-1(2H),2-oxirane]-2,3-diol, octahydro-5,6,8a-trimethyl-5-[2-(tetrahydro-3,4-dihydroxy-2,5-dimethoxy-3-furanyl)ethyl]
8-[2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)ethyl]-4a,7,8-trimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-2,3-diol
8-[2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)ethyl]-4a,7,8-trimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-2,3-diol_37.6\\%
8-[2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)ethyl]-4a,7,8-trimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-2,3-diol_major
8-[2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)ethyl]-4a,7,8-trimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-2,3-diol_minor
8-[2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)ethyl]-4a,7,8-trimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-2,3-diol_44.8\\%
Ala Asp Ile Ile
Ala Asp Ile Leu
Ala Asp Leu Ile
Ala Asp Leu Leu
Ala Glu Ile Val
Ala Glu Leu Val
Ala Glu Val Ile
Ala Glu Val Leu
Ala Gly Lys Arg
Ala Gly Arg Lys
Ala Ile Asp Ile
Ala Ile Asp Leu
Ala Ile Glu Val
Ala Ile Ile Asp
Ala Ile Leu Asp
Ala Ile Val Glu
Ala Lys Gly Arg
Ala Lys Asn Val
Ala Lys Arg Gly
Ala Lys Val Asn
Ala Leu Asp Ile
Ala Leu Asp Leu
Ala Leu Glu Val
Ala Leu Ile Asp
Ala Leu Leu Asp
Ala Leu Val Glu
Ala Asn Lys Val
Ala Asn Val Lys
Ala Arg Gly Lys
Ala Arg Lys Gly
Ala Val Glu Ile
Ala Val Glu Leu
Ala Val Ile Glu
Ala Val Lys Asn
Ala Val Leu Glu
Ala Val Asn Lys
Asp Ala Ile Ile
Asp Ala Ile Leu
Asp Ala Leu Ile
Asp Ala Leu Leu
Asp Ile Ala Ile
Asp Ile Ala Leu
Asp Ile Ile Ala
Asp Ile Leu Ala
Asp Leu Ala Ile
Asp Leu Ala Leu
Asp Leu Ile Ala
Asp Leu Leu Ala
Asp Val Val Val
Glu Ala Ile Val
Glu Ala Leu Val
Glu Ala Val Ile
Glu Ala Val Leu
Glu Gly Ile Ile
Glu Gly Ile Leu
Glu Gly Leu Ile
Glu Gly Leu Leu
Glu Ile Ala Val
Glu Ile Gly Ile
Glu Ile Gly Leu
Glu Ile Ile Gly
Glu Ile Leu Gly
Glu Ile Val Ala
Glu Leu Ala Val
Glu Leu Gly Ile
Glu Leu Gly Leu
Glu Leu Ile Gly
Glu Leu Leu Gly
Glu Leu Val Ala
Glu Val Ala Ile
Gly Ala Lys Arg
Gly Ala Arg Lys
Gly Ile Lys Asn
Gly Ile Asn Lys
Gly Lys Ala Arg
Gly Lys Ile Asn
Gly Lys Leu Asn
Gly Lys Asn Ile
Gly Lys Asn Leu
Gly Lys Gln Val
Gly Lys Arg Ala
Gly Lys Val Gln
Gly Leu Lys Asn
Gly Leu Asn Lys
Gly Asn Ile Lys
Gly Asn Lys Ile
Gly Asn Lys Leu
Gly Asn Leu Lys
Gly Gln Lys Val
Gly Gln Val Lys
Gly Arg Ala Lys
Gly Arg Lys Ala
Gly Val Lys Gln
Gly Val Gln Lys
Ile Gly Lys Asn
Ile Gly Asn Lys
Ile Lys Gly Asn
Ile Lys Asn Gly
Ile Asn Gly Lys
Ile Asn Lys Gly
Lys Ala Gly Arg
Lys Ala Asn Val
Lys Ala Arg Gly
Lys Ala Val Asn
Lys Gly Ala Arg
Lys Gly Ile Asn
Lys Gly Leu Asn
Lys Gly Asn Ile
Lys Gly Asn Leu
Lys Gly Gln Val
Lys Gly Arg Ala
Lys Gly Val Gln
Lys Ile Gly Asn
Lys Ile Asn Gly
Lys Leu Gly Asn
Lys Leu Asn Gly
Lys Asn Ala Val
Lys Asn Gly Ile
Lys Asn Gly Leu
Lys Asn Ile Gly
Lys Asn Leu Gly
Lys Asn Val Ala
Lys Gln Gly Val
Lys Gln Val Gly
Lys Arg Ala Gly
Lys Arg Gly Ala
Lys Val Ala Asn
Lys Val Gly Gln
Lys Val Asn Ala
Lys Val Gln Gly
Leu Gly Lys Asn
Leu Gly Asn Lys
Leu Lys Gly Asn
Leu Lys Asn Gly
Leu Leu Ala Asp
Leu Leu Asp Ala
Leu Leu Glu Gly
Leu Leu Gly Glu
Leu Asn Gly Lys
Leu Asn Lys Gly
Leu Pro Thr Thr
Leu Thr Pro Thr
Leu Thr Thr Pro
Leu Val Ala Glu
Leu Val Glu Ala
Asn Ala Lys Val
Asn Ala Val Lys
Asn Gly Ile Lys
Asn Gly Lys Ile
Asn Gly Lys Leu
Asn Gly Leu Lys
Asn Ile Gly Lys
Asn Ile Lys Gly
Asn Lys Ala Val
Asn Lys Gly Ile
Asn Lys Gly Leu
Asn Lys Ile Gly
Asn Lys Leu Gly
Asn Lys Val Ala
Asn Leu Gly Lys
Asn Leu Lys Gly
Asn Val Ala Lys
Asn Val Lys Ala
Pro Ile Thr Thr
Pro Leu Thr Thr
Pro Thr Ile Thr
Pro Thr Leu Thr
Pro Thr Thr Ile
Pro Thr Thr Leu
Gln Gly Lys Val
Gln Gly Val Lys
Gln Lys Gly Val
Gln Lys Val Gly
Gln Val Gly Lys
Gln Val Lys Gly
Arg Ala Gly Lys
Arg Ala Lys Gly
Arg Gly Ala Lys
Arg Gly Lys Ala
Arg Lys Ala Gly
Arg Lys Gly Ala
Thr Ile Pro Thr
Thr Ile Thr Pro
Thr Leu Pro Thr
Thr Leu Thr Pro
Thr Pro Ile Thr
Thr Pro Leu Thr
Thr Pro Thr Ile
Thr Pro Thr Leu
Thr Thr Ile Pro
Thr Thr Leu Pro
Thr Thr Pro Ile
Thr Thr Pro Leu
Val Ala Glu Ile
Val Ala Glu Leu
Val Ala Lys Asn
Val Ala Leu Glu
Val Asp Val Val
Val Glu Ala Ile
Val Glu Ala Leu
Val Glu Ile Ala
Val Glu Leu Ala
Val Gly Lys Gln
Val Gly Gln Lys
Val Ile Ala Glu
Val Ile Glu Ala
Val Lys Ala Asn
Val Lys Gly Gln
Val Lys Asn Ala
Val Lys Gln Gly
Val Leu Ala Glu
Val Leu Glu Ala
Val Asn Ala Lys
Val Asn Lys Ala
Val Gln Gly Lys
Val Gln Lys Gly
Val Val Asp Val
Val Val Val Asp
isopropyl ester
15-keto Latanoprost
AL 6598
2-(2-Methylbutanoyl)-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one
Piritramide
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AC - Diphenylpropylamine derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics
5-[2-(3,4-Dihydroxy-2,5-dimethoxytetrahydro-3-furanyl)ethyl]-5,6,8a-trimethyloctahydro-2H-spiro[naphthalene-1,2-oxirane]-2,3-diol
4,8-Bis({[dimethyl(2-methyl-2-propanyl)silyl]oxy}methyl)-1,5-diazatricyclo[5.1.0.03,5]octane-2,6-diol
EHop-016
EHop-016 is a potent and selective Rac GTPase Rac1 and Rac3 inhibitor. EHop-016 inhibits Rac1 activity with an IC50 of 1.1 μM in MDA-MB-435 cells. EHop-016 inhibits Vav2 interaction with Rac, Rac-activated PAK1, lamellipodia formation, and cell migration[1][2].
4,4,5,5-tetramethyl-2-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)anthracen-2-yl]-1,3,2-dioxaborolane
1-[2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid
Sodium Cholate
Digestion and Absorption of Fats: Bile acids are crucial for the digestion and absorption of dietary fats and fat-soluble vitamins (A, D, E, and K) in the small intestine. They achieve this by emulsifying large fat droplets into smaller droplets, increasing the surface area for action by lipase, an enzyme that breaks down fats. Cholesterol Metabolism: Bile acids are synthesized from cholesterol in the liver. They play a key role in cholesterol homeostasis by facilitating the excretion of cholesterol from the body. This process is important for regulating blood cholesterol levels. Bile Formation: Bile acids are a major component of bile, which is produced by the liver and stored in the gallbladder. Bile is released into the small intestine to aid in the digestion and absorption of fats. Hormone-like Functions: Bile acids can act as signaling molecules, influencing various metabolic processes through activation of nuclear receptors such as the farnesoid X receptor (FXR) and the G protein-coupled bile acid receptor 1 (GPBAR1, also known as TGR5). Lipid Solubility: Bile acids are amphipathic molecules, meaning they have both hydrophobic and hydrophilic regions. This property allows them to solubilize lipids and lipid-soluble substances, aiding in their transport and absorption. Microbial Metabolism: In the intestine, bile acids can influence the composition of the gut microbiota by affecting the growth of different bacterial species. The gut microbiota, in turn, can modify bile acids, influencing their function and the overall metabolic state of the host. D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
Diphenylacetylene-4,4-diboronic acid bis(pinacol) ester
Resocortol butyrate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
(2s,3s)-3-Amino-4-[(3s)-3-Fluoropyrrolidin-1-Yl]-N,N-Dimethyl-4-Oxo-2-(Trans-4-[1,2,4]triazolo[1,5-A]pyridin-5-Ylcyclohexyl)butanamide
5-[(E,5S,6S)-5,6-dihydroxy-6-[(2R,3R,5S)-5-[(2R,3S)-3-hydroxy-2-methylbutyl]-3-methyloxolan-2-yl]-3-methylhex-2-enoyl]oxypentanoic acid
Ala-Leu-Leu-Asp
A tetrapeptide composed of L-alanine, two L-leucine units, and L-aspartic acid joined in sequence by peptide linkages.
asnovolin J
A meroterpenoid with formula C26H38O5 isolated from the fungus Aspergillus novofumigatus. It is an intermediate produced in the biosynthetic pathway leading to the synthesis of novofumigatonin.
methyl (1R,2S,5S,7R,10S,11S,13R,15R)-7-hydroxy-2,6,6,10,13,15-hexamethyl-17-methylidene-14,16-dioxotetracyclo[11.3.1.02,11.05,10]heptadecane-1-carboxylate
(2S)-1-[(2R)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-1-oxopropyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid
(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
Gln-Lys-Arg
A tripeptide composed of L-glutamine, L-lysine, and L-arginine units joined in sequence by peptide linkages.
Asp-Val-Val-Val
A tetrapeptide composed of L-aspartic acid and three L-valine units joined in sequence by peptide linkages.
(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one
(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(3-pyridinylmethyl)amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one
Andrastin E
A 17-oxo steroid that is andrastin D in which the keto group at position 3 has undergone formal reduction to give the corresponding 3alpha-hydroxy compound.
Andrastin F
A 17-oxo steroid that is andrastin D in which the keto group at position 3 has undergone formal reduction to give the corresponding 3beta-hydroxy compound.
methyl (3R)-3-[(2E,6E)-9-[(2R)-3,3-dimethyloxiran-2-yl]-3,7-dimethylnona-2,6-dienyl]-6-hydroxy-2,3,5-trimethyl-4-oxocyclohexa-1,5-diene-1-carboxylate
Cholic acid (sodium)
Cholic acid sodium is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid sodium is orally active[1][2]. Cholic acid sodium is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid sodium is orally active[1][2].
(1e,3s,3ar,5r,7s,7as)-1-ethylidene-7-isopropyl-3-[(2-methylbutanoyl)oxy]-4-methylidene-2-oxo-hexahydroinden-5-yl (2e)-3-methylpent-2-enoate
1-acetyl-3a,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl 2-methylbut-2-enoate
methyl (4ar,5s,6r,8as)-5-[2-(furan-3-yl)ethyl]-5,6-dimethyl-8a-{[(3-methylbutanoyl)oxy]methyl}-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylate
(8ar)-5-methyl-3-(pentadecyloxy)-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
(1r,2s,11s,13s,14r,15s,18s,20r)-13,18-dihydroxy-1,7,11,15,19,19-hexamethyl-8,10-dioxapentacyclo[12.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]docosa-4(9),6-dien-5-one
(3r)-3-[(3as,5as,6s,7s,9as,11ar)-7-hydroxy-6-(hydroxymethyl)-3a,6,9a,11a-tetramethyl-3-oxo-4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]butanoic acid
(2r)-6-hydroxy-2-(2-hydroxypropan-2-yl)-5,5-bis(3-methylbut-2-en-1-yl)-7-(3-methylbutanoyl)-2,3-dihydro-1-benzofuran-4-one
5-(methoxycarbonyl)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl 2,3-dimethyloxirane-2-carboxylate
(3r,8as)-5-propyl-3-(tridecyloxy)-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
(1r,4s,5r,9s,10s,13r,15s)-5-(methoxycarbonyl)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl (2s,3s)-2,3-dimethyloxirane-2-carboxylate
(1e)-2-[(1s,3r,5s,12r)-3-methoxy-3,11-dimethyl-11-(4-methylpent-3-en-1-yl)-2,6-dioxatricyclo[6.4.0.0¹,⁵]dodec-8-en-12-yl]ethenyl 3-methylbut-2-enoate
15-o-methyl-14-epi-neovibsanin f
{"Ingredient_id": "HBIN001710","Ingredient_name": "15-o-methyl-14-epi-neovibsanin f","Alias": "NA","Ingredient_formula": "C26H38O5","Ingredient_Smile": "CC(=CC(=O)OC=CC1C2=C(COC2CC(=O)C)C3CC1(CCC3C(C)(C)OC)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14392","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
15-o-methylneovibsanin f
{"Ingredient_id": "HBIN001713","Ingredient_name": "15-o-methylneovibsanin f","Alias": "NA","Ingredient_formula": "C26H38O5","Ingredient_Smile": "CC(=CC(=O)OC=CC1C2=C(COC2CC(=O)C)C3CC1(CCC3C(C)(C)OC)C)C","Ingredient_weight": "430.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14607","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11154655","DrugBank_id": "NA"}
2-o-methylneovibsanin h
{"Ingredient_id": "HBIN006255","Ingredient_name": "2-o-methylneovibsanin h","Alias": "NA","Ingredient_formula": "C26H38O5","Ingredient_Smile": "CC(=CCCC1(CC(C2=C(C1C=COC(=O)C=C(C)C)C(OC2)CC(=O)C)OC)C)C","Ingredient_weight": "430.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14608","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11750791","DrugBank_id": "NA"}
2-o-methylneovibsanin i
{"Ingredient_id": "HBIN006256","Ingredient_name": "2-o-methylneovibsanin i","Alias": "NA","Ingredient_formula": "C26H38O5","Ingredient_Smile": "CC(=CCCC1(CC(C2=C(C1C=COC(=O)C=C(C)C)C(OC2)CC(=O)C)OC)C)C","Ingredient_weight": "430.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14609","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11362444","DrugBank_id": "NA"}